Avidity Biosciences
Developing innovative neuromodulation technology to treat large disease populations.
Developing innovative neuromodulation technology to treat large disease populations.
Sector
Life SciencesCategory
TherapeuticsLocation
San Diego, CAInitial Investment
2014Avidity Biosciences (NASDAQ: RNA) is a biotech company pioneering a new class of precision medicines – Antibody-siRNA Conjugates (ASC™) – which combine the strengths of monoclonal antibodies and siRNA-based therapeutics to overcome barriers to the delivery of siRNA and target genetic drivers of disease.